Skip to content
StockMarketAgent
Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

LON/0Q6H stock hub

LON/0Q6H has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0Q6His not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
42.9M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0Q6H
In the news

Latest news · LON/0Q6H

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-27.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0Q6H market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
151
Groups with data
11
Currency
NOK
Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Norway
Country code
UK
Employees
84
Employees Change
6%
Employees Change Percent
7.69
Enterprise value
NOK 66.1M
Exchange
London Stock Exchange
Financial currency
NOK
First seen
2026-05-10
Industry
Medicinal Chemicals and Botanical Products
Isin
NO0010598683
Last refreshed
2026-05-10
Market cap
NOK 42.9M
Price
NOK 1.34
Price currency
NOK
Rev Per Employee
233,255.35x
Sic
2833
Symbol
lon/0Q6H
Website
https://www.hofsethbiocare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-23.19%
EV Earnings
-6.65x
EV/FCF
-18.87x
EV/Sales
3.24x
FCF yield
-8.17%
P/B ratio
-7.7x
P/S ratio
2.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-43.79%
EBITDA Margin
-38.27%
Gross margin
30.7%
Gross Profit
NOK 5.8M
Gross Profit Growth
3.92%
Gross Profit Growth3 Y
63.64%
Gross Profit Growth5 Y
21.5%
Net Income
NOK -9.9M
Pretax Margin
-52.55%
Profit Margin
-52.62%
Profit Per Employee
NOK -122,734
ROA
-19.12
Roa5y
-17.9
ROCE
-73.34
ROIC
-27.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
-35.9%
Cagr3y
-23.81%
FCF Growth Q
-72.27%
OCF Growth Q
-23.61%
Revenue Growth
-3.46x
Revenue Growth Q
11.2x
Revenue Growth3 Y
28.63x
Revenue Growth5 Y
29.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
NOK 0.7
Assets
NOK 29.1M
Cash
NOK 4.9M
Current Assets
NOK 12.9M
Current Liabilities
NOK 19.2M
Debt
NOK 26.5M
Debt FCF
NOK -7.57
Equity
NOK -5.6M
Interest Coverage
-4.92
Liabilities
NOK 34.6M
Long Term Assets
NOK 16.2M
Long Term Liabilities
NOK 15.4M
Net Cash
NOK -21.6M
Net Cash By Market Cap
NOK -50.36
Tangible Book Value
NOK -5.8M
Tangible Book Value Per Share
NOK -0.01
WACC
5.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.67
Inventory Turnover
3.07
Net Working Capital
NOK -1.1M
Quick ratio
0.39
Working Capital
NOK -5.9M
Working Capital Turnover
NOK -0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
1Y total return
-35.89%
3Y total return
-55.78%
All Time High
3.35
All Time High Change
-60%
All Time High Date
2023-08-30
All Time Low
1.3
All Time Low Change
3.08%
All Time Low Date
2025-12-30
ATR
0.2
Beta
0.41
Ch YTD
3.08
High
1.34
High52
2.38
High52 Date
2025-05-13
High52ch
-43.7%
Low
1.34
Low52
1.3
Low52 Date
2025-12-30
Low52ch
3.08%
RSI
31.24
RSI Monthly
34.48
RSI Weekly
0
Sharpe ratio
-2.88x
Sortino ratio
-3.47
Total Return
0.2%
Tr YTD
3.08
Tr1m
-0.37%
Tr3m
3.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
NOK -8.3M
Operating margin
-43.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
120,426,252%
Net Borrowing
8,806,182.3
Shares Insiders
15.61%
Shares Institutions
20.67%
Shares Qo Q
-0.24%
Shares Yo Y
-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

42
MetricValue
Adjusted FCF
NOK -3.5M
Average Volume
7,972x
Bv Per Share
-0.01
CAPEX
NOK -1.5M
Ch1m
-0.37
Ch1y
-35.89
Ch3m
3.08
Ch3y
-55.78
Ch6m
-25.35
Change
-0.37%
Change From Open
0
Close
1.35
Days Gap
-0.37
Depreciation Amortization
1,126,479.6
Dollar Volume
38,388.3
Earnings Date
2026-05-29
EBIT
NOK -8.3M
EBITDA
NOK -7.2M
EPS
NOK -0.02
F Score
3
FCF
NOK -3.5M
FCF EV Yield
-5.3x
Financing CF
6,744,254
Fiscal Year End
December
Founded
2,000
Income Tax
NOK 12,972
Investing CF
-1,508,378
Is Primary Listing
0
Last Earnings Date
2026-03-27
Last Report Date
2025-12-31
Ma20
1.78
Ma20ch
-24.72%
Net CF
3,056,779
Next Earnings Date
2026-05-29
Open
1.34
Ppne
11,703,026.2
Price Date
2026-04-21
Relative Volume
3.59x
Revenue
18,893,683x
Tax By Revenue
0.07x
Tr6m
-25.35%
Volume
28,648
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0Q6H pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0Q6H stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-35.9%
S&P 500 1Y: n/a
3Y total return
-55.8%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0Q6H?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.7%
Share of float held by funds and institutions
Insider ownership
+15.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.2%
Negative means the company is buying back shares.
Technical

LON/0Q6H momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
31.2
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
0.41
Less volatile than the market
Sharpe ratio
-2.88
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0Q6H

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0Q6H stock rating?

lon/0Q6H is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0Q6H analysis?

The full report lives at /stocks/lon/0Q6H/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0Q6H?

The latest report frames lon/0Q6H around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0Q6H page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.